The company has analysed the data and reported their conclusions. This does need to be looked at objectively but surely they understand sufficiently to give reasoned analysis - which they indicate the results are significant. I read that there are bright spots but proof of pudding is BIT taking it further. Encouraged by following statements in conclusion comments in the poster:
"The BIT225 cohort had a significantly greater reduction of the macrophage activation marker sCD163, a good indicator of all cause morbidity and mortality in HIV-1 patients. Additional reduction of this marker in patients taking BIT225 demonstrates significant immunological benefit.
In particular:
The commencement of a decline of activated CD4+ cell levels at week 6 suggests that virus from these reservoir cells is being eradicated, and cleared by week 12 when levels return to those seen in the ART + placebo cohort."
Still, DYOR but guilty of picking up some low priced OBs this morning
- Forums
- ASX - By Stock
- BIT
- Catalysts for $1B MC?
Catalysts for $1B MC?, page-174
Featured News
Add BIT (ASX) to my watchlist
|
|||||
Last
2.7¢ |
Change
0.001(3.85%) |
Mkt cap ! $24.36M |
Open | High | Low | Value | Volume |
2.7¢ | 2.8¢ | 2.6¢ | $21.78K | 807.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 138461 | 2.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.7¢ | 194761 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 138461 | 0.026 |
10 | 880546 | 0.025 |
2 | 3373333 | 0.024 |
1 | 130000 | 0.023 |
4 | 825000 | 0.022 |
Price($) | Vol. | No. |
---|---|---|
0.027 | 194761 | 1 |
0.028 | 47808 | 2 |
0.029 | 260000 | 2 |
0.030 | 47636 | 2 |
0.031 | 159129 | 3 |
Last trade - 16.10pm 19/08/2024 (20 minute delay) ? |
Featured News
BIT (ASX) Chart |